EUVIMEDEUVIMED entdecken
Systematische Übersicht

A systematic review of the role of interleukin-17 inhibitors in bullous pemphigoid: therapeutic and paradoxical effects

Nazila Heidari, Seyedayin Hosseini, Amirhossein Heidari, Yekta Ghane, Maryam Daneshpazhooh, Hamidreza Mahmoudi

Archives of Dermatological Research · 11.03.2025 · 317 (1)

DOI: 10.1007/s00403-025-04052-x ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Archives of Dermatological Research, online erschienen am 11.03.2025. Verfasst von Nazila Heidari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, 1199663911, Iran. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Interleukin-17, Antibodies, Monoclonal, Humanized, Dermatologic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bullous pemphigoid (BP) is the most common autoimmune-driven blistering disease. The incidence of BP has been rising due to population aging and exposure to medications such as biologics. Moreover, biologics are utilized as therapeutic choices for BP treatment as they inhibit cytokines and disrupt pathogenesis pathways. Secukinumab and ixekizumab are two biologics that block interleukin (IL)-17A cytokines, a crucial factor in the autoimmune inflammatory pathway. We aim to systematically evaluate the effect of IL-17 inhibitors on treating and triggering BP disease. A systematic search was carried out up to Sept 16, 2023, in PubMed/Medline, Ovid-Embase, Scopus, and Web of Science. Clinical studies published in English were included. The search identified 282 relevant records, and ten articles were included. Moreover, one clinical trial was found through a search on Clinicaltrial.gov. Secukinumab and ixekizumab significantly improve BP lesions and blisters in combination with prednisolone or alone in BP subjects with or without concomitant psoriasis. However, ixekizumab has failed in a recent clinical trial. In contrast, BP has developed in some patients who were treated with these drugs for an underlying condition. IL-17 inhibitors exert both beneficial and paradoxical effects on BP. Further investigations are warranted to better understand the effects of these agents on BP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, BullousInterleukin-17Antibodies, Monoclonal, HumanizedDermatologic AgentsHumansTreatment OutcomeDrug Therapy, Combination

Stichwörter der Autor:innen

Bullous pemphigoidInterleukin-17 inhibitorsIxekizumabSecukinumabSystematic review

Substanzen

Interleukin-17secukinumabAntibodies, Monoclonal, HumanizedixekizumabIL17A protein, humanDermatologic Agents

Autor:innen und Institutionen

  • Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, 1199663911, Iran.
  • School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, 1199663911, Iran. maryamdanesh.pj@gmail.com.

Zitieren

APA

Heidari, N., Hosseini, S., Heidari, A., Ghane, Y., Daneshpazhooh, M., & Mahmoudi, H. (2025). A systematic review of the role of interleukin-17 inhibitors in bullous pemphigoid: therapeutic and paradoxical effects. Archives of Dermatological Research, 317(1). https://doi.org/10.1007/s00403-025-04052-x

Vancouver

Heidari N, Hosseini S, Heidari A, Ghane Y, Daneshpazhooh M, Mahmoudi H. A systematic review of the role of interleukin-17 inhibitors in bullous pemphigoid: therapeutic and paradoxical effects. Archives of Dermatological Research. 2025;317(1). doi:10.1007/s00403-025-04052-x

BibTeX
@article{Heidari2025,
  author = {Heidari, Nazila and Hosseini, Seyedayin and Heidari, Amirhossein and Ghane, Yekta and Daneshpazhooh, Maryam and Mahmoudi, Hamidreza},
  title = {A systematic review of the role of interleukin-17 inhibitors in bullous pemphigoid: therapeutic and paradoxical effects},
  journal = {Archives of Dermatological Research},
  year = {2025},
  volume = {317},
  number = {1},
  doi = {10.1007/s00403-025-04052-x}
}
Kostenlos starten →